Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

NNeuphoria Therapeutics Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
N

Neuphoria Therapeutics Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Jan 20, 2026Ryan JaneDirector8,537Restricted Stock Units—Grant / award
Jan 20, 2026Davies Peter Miles WinstonDirector8,537Restricted Stock Units—Grant / award
Jan 20, 2026Fisher AlanDirector17,073Restricted Stock Units—Grant / award
Jan 20, 2026Wilson David IanDirector8,537Restricted Stock Units—Grant / award
Oct 21, 2025Lynx1 Capital Management LP10% Owner639,110Common stock, $0.00001 par value per share—Buy
Aug 27, 2025Papapetropoulos SpyrosPresident and CEO34,559Employee Stock Option (Right-to- Buy)—Grant / award
Apr 16, 2025Papapetropoulos SpyrosPresident and CEO27,000Employee Stock Option (Right-to-Buy)—Grant / award
Apr 16, 2025Fisher AlanDirector13,566Restricted Stock Units—Grant / award
Apr 16, 2025Wilson David IanDirector6,783Restricted Stock Units—Grant / award
Apr 16, 2025Ryan JaneDirector6,783Restricted Stock Units—Grant / award
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions